Literature DB >> 27497323

IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.

Ana J Chucair-Elliott1, Jeremy Jinkins2, Meghan M Carr2, Daniel J J Carr3.   

Abstract

Herpes simplex virus type 1 (HSV-1) is a leading cause of neurotrophic keratitis characterized by decreased corneal sensation because of damage to the corneal sensory fibers. We and others have reported regression of corneal nerves during acute HSV-1 infection. To determine whether denervation is caused directly by the virus or indirectly by the elicited immune response, mice were infected with HSV-1 and topically treated with dexamethasone (DEX) or control eye drops. Corneal sensitivity was measured using a Cochet-Bonnet esthesiometer and nerve network structure via immunohistochemistry. Corneas were assessed for viral content by plaque assay, leukocyte influx by flow cytometry, and content of chemokines and inflammatory cytokines by suspension array. DEX significantly preserved corneal nerve structure and sensitivity on infection. DEX reduced myeloid and T-cell populations in the cornea and did not affect viral contents at 4 and 8 days post infection. The elevated protein contents of chemokines and inflammatory cytokines on infection were greatly suppressed by DEX. Subconjunctival delivery of neutralizing antibody against IL-6 to infected mice resulted in partial preservation of corneal nerve structure and sensitivity. Our study supports a role for the immune response, but not local virus replication in the development of HSV-1-induced neurotrophic keratitis. IL-6 is one of the factors produced by the elicited inflammatory response to HSV-1 infection contributing to nerve regression.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27497323      PMCID: PMC5222975          DOI: 10.1016/j.ajpath.2016.06.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

Review 1.  Neurotrophic keratitis.

Authors:  E A Davis; C H Dohlman
Journal:  Int Ophthalmol Clin       Date:  2001

Review 2.  Neurotrophic keratitis.

Authors:  S Bonini; P Rama; D Olzi; A Lambiase
Journal:  Eye (Lond)       Date:  2003-11       Impact factor: 3.775

Review 3.  IL-6 signal transduction and its physiological roles: the signal orchestration model.

Authors:  D Kamimura; K Ishihara; T Hirano
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-05       Impact factor: 5.545

4.  Mechanisms of herpes simplex virus type 1 reactivation.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis.

Authors:  Hongmin Yun; Alexander M Rowe; Kira L Lathrop; Stephen A K Harvey; Robert L Hendricks
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

6.  Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea.

Authors:  Bobbie Ann Austin; William P Halford; Bryan R G Williams; Daniel J J Carr
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

7.  Control of stromal keratitis by inhibition of neovascularization.

Authors:  M Zheng; M A Schwarz; S Lee; U Kumaraguru; B T Rouse
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

8.  Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells.

Authors:  Ana J Chucair-Elliott; Christopher Conrady; Min Zheng; Chandra M Kroll; Thomas E Lane; Daniel J J Carr
Journal:  Glia       Date:  2014-05-07       Impact factor: 7.452

9.  Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.

Authors:  B A Barron; L Gee; W W Hauck; N Kurinij; C R Dawson; D B Jones; K R Wilhelmus; H E Kaufman; J Sugar; R A Hyndiuk
Journal:  Ophthalmology       Date:  1994-12       Impact factor: 12.079

10.  Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate.

Authors:  Olga Weijtens; Rik C Schoemaker; Fred P H T M Romijn; Adam F Cohen; Eef G W M Lentjes; Jan C van Meurs
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

View more
  16 in total

1.  Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins.

Authors:  Daniel J J Carr; Grzegorz B Gmyrek; Adrian Filiberti; Amanda N Berube; William P Browne; Brett M Gudgel; Virginie H Sjoelund
Journal:  Immunohorizons       Date:  2020-10-09

Review 2.  Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.

Authors:  Naveen K Rajasagi; Barry T Rouse
Journal:  Microbes Infect       Date:  2018-01-09       Impact factor: 2.700

3.  Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.

Authors:  Derek J Royer; Meghan M Carr; Ana J Chucair-Elliott; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

4.  Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system.

Authors:  Ana J Chucair-Elliott; Meghan M Carr; Daniel J J Carr
Journal:  J Leukoc Biol       Date:  2017-01-23       Impact factor: 4.962

Review 5.  Regenerative therapy for the Cornea.

Authors:  Ajay Kumar; Hongmin Yun; Martha L Funderburgh; Yiqin Du
Journal:  Prog Retin Eye Res       Date:  2021-09-14       Impact factor: 21.198

6.  Varicella Zoster Virus Alters Expression of Cell Adhesion Proteins in Human Perineurial Cells via Interleukin 6.

Authors:  Anna M Blackmon; Christina N Como; Andrew N Bubak; Teresa Mescher; Dallas Jones; Maria A Nagel
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

7.  Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge.

Authors:  Daniel J J Carr; Amanda N Berube; Adrian Filiberti; Grzegorz B Gmyrek
Journal:  Vaccine       Date:  2021-04-01       Impact factor: 3.641

8.  An intact complement system dampens cornea inflammation during acute primary HSV-1 infection.

Authors:  Adrian Filiberti; Grzegorz B Gmyrek; Amanda N Berube; Derek J Royer; Daniel J J Carr
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

9.  Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy.

Authors:  Rebecca G Edwards; Sarah J Kopp; Igal Ifergan; Jr-Wen Shui; Mitchell Kronenberg; Stephen D Miller; Richard Longnecker
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

10.  Colony Stimulating Factor-1 Receptor Expressing Cells Infiltrating the Cornea Control Corneal Nerve Degeneration in Response to HSV-1 Infection.

Authors:  Ana J Chucair-Elliott; Hem R Gurung; Meghan M Carr; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.